INVE Technologies, Inc. (INVE) is the Santa Ana, California-based company formerly known as Identiv. It sold its RFID and Bluetooth smart-label business to Trackonomy Systems in September 2026, changed its name, and now operates as a small-cap shell-in-transition with no commercial revenue, roughly $87 million of cash, about $50 million of Trackonomy preferred stock, and no debt. Its stated plan is to acquire compliance-focused software businesses around a "Physical AI" thesis.
The stock traded at $2.30 shortly after Friday's open, down $0.35 or 13.21% from Thursday's $2.65 close. The decline followed the company's disclosure of preliminary results from its modified Dutch auction self-tender, which expired at 5:00 p.m. New York time on November 19.
Based on the depositary's preliminary count, approximately 10,742,030 shares were properly tendered at or below $2.85 — far more than the company needed. INVE expects to purchase about 7,494,734 shares at $2.85 apiece, roughly $21.4 million in total, including 477,191 shares bought under its right to add up to 2% of outstanding stock. That represents approximately 31.4% of shares outstanding as of October 19.
The offer was heavily oversubscribed, producing a preliminary proration factor of just 69.8%. In the sessions before expiration, the stock traded well below the $2.85 purchase price, which gave short-horizon and arbitrage buyers a reason to accumulate shares specifically to tender them at a premium to market. That bid support has now disappeared.
The mechanical consequence of 69.8% proration is that tendering holders will get back roughly 3.25 million shares they had submitted for purchase. Those returned shares typically find their way to the market once the offer closes and the arbitrage spread is gone, adding supply just as the price floor created by the tender evaporates.
Because the company has no earnings stream — third-quarter revenue of $3.09 million covered only activity through the September 15 asset-sale closing — there is no fundamental anchor to absorb that supply. The share price is effectively a market estimate of cash, the illiquid Trackonomy stake, and the credibility of the acquisition plan, which makes it unusually sensitive to flows.
There was no sector-wide or macroeconomic catalyst behind the move. The decline was narrow and company-specific, and the stock diverged from the broader technology complex rather than following it. No analyst rating change accompanied the drop; coverage is thin, with a single analyst tracked on the name.
Early turnover in the first minutes of Friday's session tracked the stock's normal opening pace against a three-month average near 478,000 shares, suggesting the move was price-driven rather than a surge of panic volume — though the buyback will materially shrink the tradable float once it settles.
Technically, the stock broke below the $2.55 to $2.72 band that contained it for most of November and now trades roughly 4% above its 52-week low of $2.21. For reference, the shares closed at $2.22 on October 20, the session before the tender was announced, and jumped 25% the following day.
The score runs from 0, meaning no meaningful news and a move that is ordinary for the stock, to 100, meaning transformative news and an extreme, rare price move. This event earns 52 out of 100.
The verified news was moderate rather than transformative: a completed, widely anticipated capital return that was oversubscribed and priced at the low end of the announced range, with no change to the underlying business. The price reaction, however, was far outside normal behavior — about seven times the stock's average absolute daily move of roughly 1.9% over the past 60 sessions, and larger than all but one session in that span, the 25% gain on October 21. A modest catalyst paired with a statistically unusual move produces a mid-range score.
Confirmation of the final share count, purchase price and proration factor is due after the guaranteed delivery period, followed by payment for accepted shares and the return of the rest — a process that will dictate near-term supply. Management has said it expects no commercial operating revenue and will not provide guidance while it hunts for acquisitions, with roughly $30 million earmarked for software deals and $12 million to $15 million a year allocated to corporate overhead over an estimated three-year period. Investors will weigh how quickly that capital is deployed and at what valuation, alongside the risk that the Trackonomy preferred stake cannot be readily monetized. Any equity-funded acquisition below the $4.00 preferred conversion price would also dilute common holders.
Tickeron's Trending AI Robots page curates the automated strategies performing best under current market conditions, drawn from a library of hundreds of AI trading bots spanning thousands of tickers. Bots differ by strategy, timeframe, performance metrics, and the symbols they trade, so the featured list rotates as conditions change. It is a practical starting point for traders who want to see which approaches are working right now — review the current lineup and compare the metrics yourself.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
INVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 41 cases where INVE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 80%.
The RSI Indicator entered the oversold zone -- be on the watch for INVE's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 67 cases where INVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The 10-day moving average for INVE crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +5.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVE advanced for three days, in 177 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVE as a result. In 78 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for INVE turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 43 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
INVE moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for INVE entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.474) is normal, around the industry mean (2.853). P/E Ratio (-3.881) is within average values for comparable stocks, (24.804). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.215). Dividend Yield (0.000) settles around the average of (0.060) among similar stocks. P/S Ratio (2.532) is also within normal values, averaging (1.867).
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. INVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of ID and security systems
Industry BuildingProducts